Article Figures & Data
Tables
- Table 1:
Outcomes after flow-diversion treatment of unruptured nonsaccular intracranial aneurysms
Variables Results of Systematic Review and Meta-Analysis No. of Articles Statistic (95% CI) (I2) Angiographic outcomes Rate of successful stent deployment 178/181 = 96% 11 (93–98) (I2 = 0%) Long-term aneurysm adequate occlusion rate 137/168 = 85.3% 12 (78.2–92.4) (I2 = 42.3%) Long-term aneurysm complete occlusion rate 128/168 = 78.8% 12 (72.8–84.8) (I2 = 0%) Long-term adequate occlusion rate (fusiform aneurysms) 116/146 = 83% 11 (74–92) (I2 = 48%) Long-term adequate occlusion rate (dissecting aneurysms) 33/36 = 89% 4 (80–98) (I2 = 0%) Long-term occlusion rate among anterior circulation 51/61 = 87.5% 6 (79–95) (I2 = 0%) Long-term occlusion rate among posterior circulation 86/107 = 83% 6 (71–95) (I2 = 60%) Long-term adequate occlusion rate (PED) 118/149 = 82% 8 (75–90) (I2 = 25%) Long-term adequate occlusion rate (other devices) 21/23 = 90% 3 (81–98) (I2 = 0%) Treatment-related complications and clinical outcomes Overall treatment-related complications 41/213 = 17.4% 16 (12.5–22.4) (I2 = 0%) Transient complications 21/213 = 9% 15 (5.6–13) (I2 = 0%) Permanent complications 20/213 = 8% 15 (5–12) (I2 = 0%) Ischemic complications 37/213 = 15% 15 (10–20) (I2 = 0%) Hemorrhagic complications 4/213 = 3% 15 (1.2–6) (I2 = 0%) Treatment-related complications (fusiform aneurysms) 35/162 = 17% 11 (10–25) (I2 = 24%) Treatment-related complications (dissecting aneurysms) 11/51 = 19% 4 (10–31) (I2 = 0%) Treatment-related complications among anterior circulation 13/81 = 14% 8 (7–22) (I2 = 0%) Treatment-related complications among posterior circulation 28/132 = 20% 8 (3–13) (I2 = 0%) Treatment-related complications (PED) 19/110 = 15% 9 (9–21) (I2 = 0%) Treatment-related complications (other devices) 3/23 = 12% 3 (6–24) (I2 = 0%) Periprocedural/early complications (within 30 days) 10/213 = 2.5% 15 (1–4) (I2 = 0%) Delayed complications (after 30 days) 31/213 = 12% 15 (7–17) (I2 = 35%) Premature discontinuation of AT and related ischemic events 5/93 = 5% 8 (2–9) (I2 = 0%) Treatment-related mortality 1/213 = 2% 15 (0.2–3.5) (I2 = 0%) Overall rate of good neurologic outcome 154/187 = 87% 10 (79–95) (I2 = 60%) Occlusion of covered branches 5/72 = 7% 10 (2–13) (I2 = 0%) Symptoms related to occlusion or impaired flow of covered branches 3/72 = 3% 10 (0.5–9) (I2 = 0%) Note:—AT indicates antiplatelet therapy.
- Table 2:
Univariate and multivariate analysis of predicting factors for aneurysm occlusion and treatment-related complications
Univariate, P Value Univariate, OR Multivariate Odds Ratio 95% CI P Value Independent variables for occlusion Type of FD (PED vs other) 0.22 1.2 Patient age (younger than 60 vs older than 60 yr) 0.21 2.6 Aneurysm size (large vs small)a 0.13 1.7 1.5 0.2–6.4 .81 Type of aneurysm (dissecting vs fusiform) 0.06 2.5 1.7 0.4–2.4 .35 Aneurysm location (AC vs PC) 0.11 3.1 0.5 0.2–0.7 .38 Independent variables for complications Type of FD (PED vs other) 0.94 1.1 Patient age (younger than 60 vs older than 60 yr) 0.46 1.5 Aneurysm size (large vs small)a 0.03 4.5 6.6 1.3–15 .02 Type of aneurysm (fusiform vs dissecting) 0.27 0.8 Aneurysm location (AC vs PC) 0.04 0.7 0.3 0.6–1.8 .09 Note:—OR indicates odds ratio.
↵a Small aneurysms, ≤10 mm; large aneurysms, ≥10 mm.